首页> 外文期刊>Clinical and experimental pharmacology & physiology >Membrane-bound and releasable nucleotidase activities: Differences in canine mesenteric artery and vein.
【24h】

Membrane-bound and releasable nucleotidase activities: Differences in canine mesenteric artery and vein.

机译:膜结合的和可释放的核苷酸酶活性:犬肠系膜动脉和静脉的差异。

获取原文
获取原文并翻译 | 示例
           

摘要

1. At least two enzymatic activities are proposed to degrade the extracellular ATP: (i) ubiquitously expressed membrane-bound enzymes (ecto-nucleotidases); and (ii) soluble (releasable) nucleotidases that are released during stimulation of sympathetic nerves and break down neuronal ATP. No quantitative data have placed the magnitude of these nucleotidase activities into a physiological perspective of neurovascular control. 2. We studied comparatively the membrane-bound and releasable nucleotidase activities in canine isolated inferior mesenteric arteries and veins using 1,N6-etheno(epsilon)-nucleotides (i.e. epsilon-ATP, epsilon-ADP, epsilon-AMP and epsilon-adenosine) as exogenous substrates. The enzymatic activities were estimated by measuring the disappearance of the epsilon-substrate and appearance of epsilon-products by means of HPLC-fluorescence detection during either stimulation of sympathetic perivascular nerves (releasable activity) or in the absence of nerve stimulation (ecto-nucleotidase activity). 3. Incubation of vascular segments with 50 nmol/L epsilon-ATP for 60 min resulted in a decrease of the epsilon-ATP substrate by 63.5 +/- 4.6 and 91.2 +/- 6.2% in the artery and vein, respectively. In contrast, the decrease of the epsilon-ATP during electrical field stimulation (EFS; 16 Hz, 0.3 msec, 2 min) was 39.8 +/- 4.2% in the artery and 13.1 +/- 7.3% in the vein. Therefore, the mesenteric arteries demonstrate a greater releasable ATPase activity and a weaker ecto-ATPase activity than mesenteric veins. 4. The degradation of epsilon-ADP and epsilon-AMP was similar in both blood vessels under either experimental protocol. The epsilon-adenosine was not significantly degraded in the absence or presence of EFS. 5. These data implicate a differential removal of extracellular ATP as a potential mechanism of serving resistance and capacitance in the splanchnic circulation.
机译:1.至少有两种酶促活性可以降解细胞外ATP:(i)普遍表达的膜结合酶(外切核苷酸酶); (ii)在刺激交感神经期间释放的可溶性(可释放)核苷酸酶并破坏神经元ATP。尚无定量数据将这些核苷酸酶活性的大小纳入神经血管控制的生理视野。 2.我们比较研究了使用1,N6-乙(ε)-核苷酸(即ε-ATP,ε-ADP,ε-AMP和ε-腺苷)在犬分离的肠系膜下动脉和静脉中膜结合和可释放的核苷酸酶活性。作为外源底物。通过在刺激交感神经周围神经(可释放活性)或不存在神经刺激(外切核苷酸酶活性)过程中通过HPLC荧光检测来测量ε底物的消失和ε产物的外观来估计酶活性。 )。 3.将血管段与50 nmol / L epsilon-ATP孵育60分钟,可使动脉和静脉中epsilon-ATP底物分别减少63.5 +/- 4.6和91.2 +/- 6.2%。相反,在电场刺激(EFS; 16 Hz,0.3毫秒,2分钟)期间,ε-ATP的减少在动脉中为39.8 +/- 4.2%,在静脉中为13.1 +/- 7.3%。因此,与肠系膜静脉相比,肠系膜动脉显示出更大的可释放ATPase活性和较弱的ecto-ATPase活性。 4.在任一实验方案下,在两个血管中ε-ADP和ε-AMP的降解相似。在不存在或存在EFS的情况下,ε-腺苷并没有明显降解。 5.这些数据暗示细胞内ATP的差异去除是内脏循环中抵抗阻力和电容的潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号